Kevin Blake
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
-
- Birth, Development, and Health
- Pharmaceutical studies and practices
Papers in
-
- Birth, Development, and Health 5
-
- Pharmacovigilance and Adverse Drug Reactions 8
- Co-authors
- John P. Newnham (8 shared papers)Lawrence J. Beilin (5 shared papers)Fiona Stanley (4 shared papers)Louis I. Landau (4 shared papers)Lyle C. Gurrin (4 shared papers)Garth Kendall (4 shared papers)Sharon Evans (3 shared papers)Wendy H. Oddy (3 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Pharmacoepidemiology and Drug Safety (6 papers)Journal of Hypertension (2 papers)Pharmaceutics (2 papers)Pediatric Drugs (2 papers)
- Partner nations
- NetherlandsAustraliaSweden
In The Last Decade
Kevin Blake
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 118
- Toxicology 106
- Pediatrics, Perinatology and Child Health 339
- Obstetrics and Gynecology 113
- Pharmacology 89
- Statistics and Probability 69
Countries citing papers authored by Kevin Blake
This map shows the geographic impact of Kevin Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Blake more than expected).
Fields of papers citing papers by Kevin Blake
This network shows the impact of papers produced by Kevin Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Blake. The network helps show where Kevin Blake may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Blake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 165 | |
| 2 | 2004 | 135 | |
| 3 | 2016 | 112 | |
| 4 | 2006 | 103 | |
| 5 | 2005 | 81 | |
| 6 | 2002 | 62 | |
| 7 | 2014 | 50 | |
| 8 | The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology (Revision 1, 2012, Revision 2, 2013, Revision 3, 2014)). | 2012 | 49 |
| 9 | 2014 | 43 | |
| 10 | 2019 | 36 | |
| 11 | 2011 | 34 | |
| 12 | 2002 | 28 | |
| 13 | 2012 | 25 | |
| 14 | 2017 | 25 | |
| 15 | 2001 | 25 | |
| 16 | 2000 | 20 | |
| 17 | 2004 | 19 | |
| 18 | 2015 | 16 | |
| 19 | 2019 | 15 | |
| 20 | 2012 | 14 |
About Kevin Blake
Kevin Blake is a scholar working on Pediatrics, Perinatology and Child Health, Toxicology, Economics and Econometrics, Immunology and Obstetrics and Gynecology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Biosimilars and Bioanalytical Methods (6 papers), Pharmaceutical Economics and Policy (5 papers), Statistical Methods in Clinical Trials (5 papers), Birth, Development, and Health (5 papers), Pregnancy and preeclampsia studies (4 papers), Gestational Diabetes Research and Management (3 papers) and Pharmaceutical industry and healthcare (3 papers). The work is most often cited by research in Toxicology (106 citations), Pediatrics, Perinatology and Child Health (339 citations), Obstetrics and Gynecology (113 citations), Pharmacology (89 citations) and Statistics and Probability (69 citations). Kevin Blake has collaborated with scholars based in Netherlands, Australia and Sweden. Frequent co-authors include John P. Newnham, Lawrence J. Beilin, Fiona Stanley, Louis I. Landau, Lyle C. Gurrin, Garth Kendall, Sharon Evans, Wendy H. Oddy, Peter Arlett and Dorota A. Doherty. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacoepidemiology and Drug Safety, Journal of Hypertension, Pharmaceutics and Pediatric Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.